A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

September 17, 2017

Study Completion Date

September 17, 2017

Conditions
Chronic Total Occlusion
Interventions
DEVICE

NovaCross

A device that is intended to asisst interventional cardiologists during catheterization to cross and open coronary chronic total occlusions

Trial Locations (1)

Unknown

Szpital Uniwersytecki w Krakowie, Krakow

All Listed Sponsors
lead

Nitiloop Ltd.

INDUSTRY

NCT04862559 - A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions | Biotech Hunter | Biotech Hunter